Overview
Toshifumi Azuma practices in Chiyoda, Japan. Azuma is rated as a Distinguished expert by MediFind in the treatment of Cleidocranial Dysplasia. Their top areas of expertise are Nevoid Basal Cell Carcinoma Syndrome, Cleidocranial Dysplasia, Basal Cell Skin Cancer, and Epidermoid Cyst.
Their clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Cleidocranial Dysplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cleidocranial DysplasiaAzuma isDistinguished. Learn about Cleidocranial Dysplasia.
- Nevoid Basal Cell Carcinoma Syndrome
- Advanced
- Basal Cell Skin CancerAzuma isAdvanced. Learn about Basal Cell Skin Cancer.
- Experienced
- Epidermoid CystAzuma isExperienced. Learn about Epidermoid Cyst.
- Fibrous DysplasiaAzuma isExperienced. Learn about Fibrous Dysplasia.
- Hajdu-Cheney SyndromeAzuma isExperienced. Learn about Hajdu-Cheney Syndrome.
- Hereditary Sensory and Autonomic Neuropathy Type 2
- OsteoporosisAzuma isExperienced. Learn about Osteoporosis.
- Teratoma of the MediastinumAzuma isExperienced. Learn about Teratoma of the Mediastinum.